AAPP partnered with Pharmacy Times to record a Pharmacy Focus podcast focused on emerging trends in psychiatric pharmacotherapy as presented at AAPP 2026, held April 19-22 in WA. Moderator Bob Haight, PharmD, BCPP, AAPP Annual Meeting Director and Past President, Clinical Application Series Chair Archana Jhawar, PharmD, BCPP, and Chelsea Di Polito, PharmD, BCPP, Annual Meeting Chair, shared insights gained on newer psychiatric medications and how these newer therapies fit into clinical decision-making, especially given considerations like cost, monitoring requirements, and patient-specific factors. The episode also explores cutting-edge research and practice challenges, including the growing interest in GLP-1 receptor agonists for substance use disorders, evolving strategies for clozapine monitoring following REMS changes, and advancements in long-acting injectable antipsychotics that improve flexibility, adherence, and patient-centered care. Tune in to hear the major takeaways and to see how AAPP’s Annual Meeting provides a valuable forum for translating emerging evidence into practical strategies that can be immediately applied in clinical practice.